Keros Therapeutics
KROS
$57.40
Share price
-0.55%
Change (1 day)
24.59%
Change (1 year)
Categories
Keros Therapeutics (KROS) - Net assets
Net assets on the balance sheet as of December 2023 : $0.33 B
According to Keros Therapeutics's latest financial reports the company has $0.33 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Keros Therapeutics - Net assets on balance sheet (from 2019 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $0.33 B | 19.75% |
| 2022-12-31 | $0.27 B | 14.08% |
| 2021-12-31 | $0.24 B | -7.09% |
| 2020-12-31 | $0.26 B | 52772.93% |
| 2019-12-31 | $0.49 M | -96.12% |
| 2018-12-31 | $12.75 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.22 B | -32.55% | 🇺🇸 USA |